首页 > 最新文献

Vaccine最新文献

英文 中文
Prediction of measles cases in US counties: A machine learning approach. 预测美国各县的麻疹病例:机器学习方法。
Pub Date : 2024-09-06 DOI: 10.1016/j.vaccine.2024.126289
Stephanie A Kujawski, Boshu Ru, Nelson Lee Afanador, James H Conway, Richard Baumgartner, Manjiri Pawaskar

Background: Although measles was declared eliminated from the United States in 2000, the frequency of measles outbreaks has increased in recent years. The ability to predict the locations of future cases could aid efforts to prevent and contain measles in the United States.

Methods: We estimated county-level measles risk using a machine learning model with 17 predictor variables, which was trained on 2014 and 2018 United States county-level measles case data and tested on data from 2019. We compared the predicted and actual locations of 2019 measles cases.

Results: The model accurately predicted 95 % (specificity) of United States counties without measles cases and 72 % (sensitivity) of the United States counties that experienced ≥1 measles case in 2019, accounting for 94 % of all measles cases in 2019. Among the top 30 counties with the highest risk scores, the model accurately predicted 22 (73 %) counties with a measles case in 2019, corresponding to 72 % of all measles cases.

Conclusions: This machine learning model accurately predicted a majority of the United States counties at high risk for measles and could be used as a framework by state and national health agencies in their measles prevention and containment efforts.

背景:尽管美国已于 2000 年宣布消灭麻疹,但近年来麻疹爆发的频率却在增加。预测未来病例发生地点的能力有助于美国预防和控制麻疹的工作:我们使用一个包含 17 个预测变量的机器学习模型来估计县级麻疹风险,该模型在 2014 年和 2018 年美国县级麻疹病例数据上进行了训练,并在 2019 年的数据上进行了测试。我们比较了 2019 年麻疹病例的预测地点和实际地点:该模型准确预测了 95%(特异性)的美国无麻疹病例县和 72%(灵敏性)的美国 2019 年麻疹病例≥1 例的县,占 2019 年所有麻疹病例的 94%。在风险评分最高的前30个县中,该模型准确预测了22个(73%)在2019年出现麻疹病例的县,相当于所有麻疹病例的72%:该机器学习模型准确预测了美国大部分麻疹高风险县,可作为各州和国家卫生机构预防和遏制麻疹工作的框架。
{"title":"Prediction of measles cases in US counties: A machine learning approach.","authors":"Stephanie A Kujawski, Boshu Ru, Nelson Lee Afanador, James H Conway, Richard Baumgartner, Manjiri Pawaskar","doi":"10.1016/j.vaccine.2024.126289","DOIUrl":"https://doi.org/10.1016/j.vaccine.2024.126289","url":null,"abstract":"<p><strong>Background: </strong>Although measles was declared eliminated from the United States in 2000, the frequency of measles outbreaks has increased in recent years. The ability to predict the locations of future cases could aid efforts to prevent and contain measles in the United States.</p><p><strong>Methods: </strong>We estimated county-level measles risk using a machine learning model with 17 predictor variables, which was trained on 2014 and 2018 United States county-level measles case data and tested on data from 2019. We compared the predicted and actual locations of 2019 measles cases.</p><p><strong>Results: </strong>The model accurately predicted 95 % (specificity) of United States counties without measles cases and 72 % (sensitivity) of the United States counties that experienced ≥1 measles case in 2019, accounting for 94 % of all measles cases in 2019. Among the top 30 counties with the highest risk scores, the model accurately predicted 22 (73 %) counties with a measles case in 2019, corresponding to 72 % of all measles cases.</p><p><strong>Conclusions: </strong>This machine learning model accurately predicted a majority of the United States counties at high risk for measles and could be used as a framework by state and national health agencies in their measles prevention and containment efforts.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142147286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The partnership for international vaccine initiatives: The importance and opportunity to develop influenza vaccination programs in low- and middle-income countries. 国际疫苗计划伙伴关系:在中低收入国家制定流感疫苗接种计划的重要性和机遇。
Pub Date : 2024-08-29 DOI: 10.1016/j.vaccine.2024.126255
Joseph S Bresee, Kathryn E Lafond
{"title":"The partnership for international vaccine initiatives: The importance and opportunity to develop influenza vaccination programs in low- and middle-income countries.","authors":"Joseph S Bresee, Kathryn E Lafond","doi":"10.1016/j.vaccine.2024.126255","DOIUrl":"https://doi.org/10.1016/j.vaccine.2024.126255","url":null,"abstract":"","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral supplementation with postbiotics modulates the immune response produced by myxomatosis vaccination in wild rabbits. 口服补充益生菌可调节野兔接种霉形体病疫苗后产生的免疫反应。
Pub Date : 2024-08-13 Epub Date: 2024-05-17 DOI: 10.1016/j.vaccine.2024.05.026
E J García-Vicente, I Rey-Casero, M Martín, A Pérez, M Benito-Murcia, D Risco

Rabbits (Oryctolagus cuniculus) are vitally important species in the Iberian Peninsula ecosystem. However, since 1950, there has been a significant population decline, with major repercussions. This situation is mainly due to the presence of infectious diseases, such as myxomatosis, which is expanding and is characterized by severe and fatal clinical manifestations. Current control measures, mainly those based on vaccinations, are ineffective. Therefore, new strategies need to be developed and implemented. This study aimed to evaluate whether supplementation with postbiotic products modulates the immune response in wild rabbits vaccinated against myxomatosis. For this purpose, two groups of rabbits were established: a control group fed with standard feed ad libitum from weaning (28 days) until two months of age, and a treated group, which was fed under the same conditions but supplemented with postbiotics (3 kg/Tm). All the studied rabbits were vaccinated against this disease during weaning. In addition, a blood samples were obtained from all animals immediately before vaccination and 30 days later, which allowed us to evaluate the level of antibodies against myxomatosis virus (ELISA detection) and the relative expression of gene encoding to cytokines related to the immune response (IL6, TNFα and IFNγ), at both times of the experience. Weight and length measurements were also taken at both times to calculate body index and mean daily gain (MDG). No statistically significant differences in growth parameters were observed. There were also no differences in the serological response among groups. However, a relative underexpression of gene codifying to TNFα (p-value = 0.03683) and a higher expression on IFNγ (p-value = 0.045) were observed in the treated group. This modulation in cytokines could lead to less severe lesions in wild rabbit naturally infected with myxomatosis virus.

兔子(Oryctolagus cuniculus)是伊比利亚半岛生态系统中极其重要的物种。然而,自 1950 年以来,兔子数量大幅减少,造成了严重影响。造成这种情况的主要原因是存在传染病,例如蕈蚊病,这种疾病正在蔓延,其特点是临床表现严重且致命。目前的控制措施,主要是以疫苗接种为基础的措施,效果不佳。因此,需要制定和实施新的策略。本研究旨在评估补充益生后产品是否会调节接种过肌瘤病疫苗的野兔的免疫反应。为此,研究人员设立了两组兔子:一组为对照组,从断奶(28 天)起至两个月大期间自由采食标准饲料;另一组为治疗组,在相同条件下饲喂,但添加了益生菌(3 kg/Tm)。所有被研究的兔子都在断奶期间接种了预防该疾病的疫苗。此外,我们还在接种疫苗前和接种疫苗 30 天后采集了所有动物的血液样本,以评估这两个时间段兔子体内的肌瘤病毒抗体水平(ELISA 检测)和免疫反应相关细胞因子(IL6、TNFα 和 IFNγ)基因的相对表达量。还在两个时间段测量了体重和身长,以计算身体指数和平均日增重(MDG)。没有观察到生长参数有明显的统计学差异。各组之间的血清反应也没有差异。不过,在治疗组中观察到 TNFα 的编码基因表达相对较低(p 值 = 0.03683),而 IFNγ 的表达较高(p 值 = 0.045)。细胞因子的这种变化可能会使自然感染肌瘤病毒的野兔的病变程度减轻。
{"title":"Oral supplementation with postbiotics modulates the immune response produced by myxomatosis vaccination in wild rabbits.","authors":"E J García-Vicente, I Rey-Casero, M Martín, A Pérez, M Benito-Murcia, D Risco","doi":"10.1016/j.vaccine.2024.05.026","DOIUrl":"10.1016/j.vaccine.2024.05.026","url":null,"abstract":"<p><p>Rabbits (Oryctolagus cuniculus) are vitally important species in the Iberian Peninsula ecosystem. However, since 1950, there has been a significant population decline, with major repercussions. This situation is mainly due to the presence of infectious diseases, such as myxomatosis, which is expanding and is characterized by severe and fatal clinical manifestations. Current control measures, mainly those based on vaccinations, are ineffective. Therefore, new strategies need to be developed and implemented. This study aimed to evaluate whether supplementation with postbiotic products modulates the immune response in wild rabbits vaccinated against myxomatosis. For this purpose, two groups of rabbits were established: a control group fed with standard feed ad libitum from weaning (28 days) until two months of age, and a treated group, which was fed under the same conditions but supplemented with postbiotics (3 kg/Tm). All the studied rabbits were vaccinated against this disease during weaning. In addition, a blood samples were obtained from all animals immediately before vaccination and 30 days later, which allowed us to evaluate the level of antibodies against myxomatosis virus (ELISA detection) and the relative expression of gene encoding to cytokines related to the immune response (IL6, TNFα and IFNγ), at both times of the experience. Weight and length measurements were also taken at both times to calculate body index and mean daily gain (MDG). No statistically significant differences in growth parameters were observed. There were also no differences in the serological response among groups. However, a relative underexpression of gene codifying to TNFα (p-value = 0.03683) and a higher expression on IFNγ (p-value = 0.045) were observed in the treated group. This modulation in cytokines could lead to less severe lesions in wild rabbit naturally infected with myxomatosis virus.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding structural inequities in Covid-19 vaccine access and uptake among disability, transgender and gender-diverse communities in India. 了解印度残疾、变性和性别多元化群体在获得和接种 Covid-19 疫苗方面存在的结构性不平等。
Pub Date : 2024-08-07 DOI: 10.1016/j.vaccine.2024.126174
Sharin D'souza, Bhakti Ghatole, Harikeerthan Raghuram, Shreyus Sukhija, Satendra Singh, Aqsa Shaikh, Sunita Sheel Bandewar, Anant Bhan

Introduction: Undervaccination and vaccination-related anxieties among marginalised communities like the transgender and gender-diverse (TGD) and disability communities are underexplored in the Indian context. Our study seeks to understand the role of structural and historical inequities in shaping COVID-19 vaccine access for the two communities in India.

Methods: Using a participatory qualitative research approach, TGD and disabled individuals were involved in and consulted throughout the research process. We interviewed 45 individuals for our study, hailing from the two communities and other key stakeholders and health system representatives involved in vaccination roll-out in India. We conducted an inductive thematic analysis guided by the socio-ecological model and intersectionality approach.

Results: Despite intent to get vaccinated among most participants, several structural barriers shaped COVID-19 vaccine access for people from the TGD and disability community. This included information and communication gaps with respect to the specific health needs of the two communities, barriers related to vaccine registration, data collection, transport, infrastructure and actual or anticipated mistreatment at vaccine centres. Each emergent structural gap in vaccination had parallels in past health systems experiences, pointing to the longstanding and pervasive inequities within health and allied systems which impact how communities perceive and respond to new health system interventions.

Conclusion: This study uncovers the structural inequities within health systems that have permeated the planning, design and outreach of COVID-19 vaccination programs in India. Moving beyond notions of vaccine hesitancy among the TGD and disability community, we underscore the importance of socio-historical contexts of marginalisation and advocate for systems to recognise these contexts and respond equitably to the vaccination and health needs of the two communities. While some challenges among the two communities were distinct, the study explores how a shared experience of exclusion from public systems can provide avenues for cross-movement advocacy and solidarity, and help inform health system reforms.

导言:在印度,变性人和性别多元化者 (TGD) 以及残疾人等边缘化群体的疫苗接种不足以及与疫苗接种相关的焦虑尚未得到充分探讨。我们的研究旨在了解结构性和历史性不平等在影响印度这两个群体获得 COVID-19 疫苗方面所起的作用:采用参与式定性研究方法,在整个研究过程中,我们都参与并咨询了创伤后和残疾人士。在研究过程中,我们采访了 45 位来自这两个社区的人士以及参与印度疫苗接种推广工作的其他主要利益相关者和医疗系统代表。在社会生态模式和交叉性方法的指导下,我们进行了归纳式专题分析:结果:尽管大多数参与者都有接种疫苗的意愿,但一些结构性障碍影响了 TGD 和残疾人群体获得 COVID-19 疫苗。这包括与这两个群体的特殊健康需求相关的信息和沟通差距,与疫苗登记、数据收集、交通、基础设施相关的障碍,以及疫苗接种中心实际存在或预期存在的虐待行为。疫苗接种中出现的每一个结构性差距都与过去卫生系统的经验相似,表明卫生及相关系统中长期存在的普遍不平等现象影响了社区对新卫生系统干预措施的看法和反应:本研究揭示了印度 COVID-19 疫苗接种计划的规划、设计和推广过程中普遍存在的卫生系统内部的结构性不平等。我们超越了TGD和残疾人群体对疫苗犹豫不决的概念,强调了边缘化的社会历史背景的重要性,并倡导医疗系统认识到这些背景,公平地满足这两个群体的疫苗接种和健康需求。虽然这两个群体面临的一些挑战各不相同,但本研究探讨了公共系统排斥的共同经历如何为跨运动倡导和团结提供途径,并有助于为卫生系统改革提供信息。
{"title":"Understanding structural inequities in Covid-19 vaccine access and uptake among disability, transgender and gender-diverse communities in India.","authors":"Sharin D'souza, Bhakti Ghatole, Harikeerthan Raghuram, Shreyus Sukhija, Satendra Singh, Aqsa Shaikh, Sunita Sheel Bandewar, Anant Bhan","doi":"10.1016/j.vaccine.2024.126174","DOIUrl":"https://doi.org/10.1016/j.vaccine.2024.126174","url":null,"abstract":"<p><strong>Introduction: </strong>Undervaccination and vaccination-related anxieties among marginalised communities like the transgender and gender-diverse (TGD) and disability communities are underexplored in the Indian context. Our study seeks to understand the role of structural and historical inequities in shaping COVID-19 vaccine access for the two communities in India.</p><p><strong>Methods: </strong>Using a participatory qualitative research approach, TGD and disabled individuals were involved in and consulted throughout the research process. We interviewed 45 individuals for our study, hailing from the two communities and other key stakeholders and health system representatives involved in vaccination roll-out in India. We conducted an inductive thematic analysis guided by the socio-ecological model and intersectionality approach.</p><p><strong>Results: </strong>Despite intent to get vaccinated among most participants, several structural barriers shaped COVID-19 vaccine access for people from the TGD and disability community. This included information and communication gaps with respect to the specific health needs of the two communities, barriers related to vaccine registration, data collection, transport, infrastructure and actual or anticipated mistreatment at vaccine centres. Each emergent structural gap in vaccination had parallels in past health systems experiences, pointing to the longstanding and pervasive inequities within health and allied systems which impact how communities perceive and respond to new health system interventions.</p><p><strong>Conclusion: </strong>This study uncovers the structural inequities within health systems that have permeated the planning, design and outreach of COVID-19 vaccination programs in India. Moving beyond notions of vaccine hesitancy among the TGD and disability community, we underscore the importance of socio-historical contexts of marginalisation and advocate for systems to recognise these contexts and respond equitably to the vaccination and health needs of the two communities. While some challenges among the two communities were distinct, the study explores how a shared experience of exclusion from public systems can provide avenues for cross-movement advocacy and solidarity, and help inform health system reforms.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare personnel acceptance and recommendations for influenza vaccine in twelve low- and middle-income countries: A pooled analysis from 2018 to 2020. 十二个中低收入国家医护人员对流感疫苗的接受程度和建议:2018年至2020年的汇总分析。
Pub Date : 2024-08-02 DOI: 10.1016/j.vaccine.2024.01.095
Margaret McCarron, Perrine Marcenac, Tat S Yau, Kathryn E Lafond, Malembe S Ebama, Lindsey M Duca, Gayane Sahakyan, Silvia Bino, Daouda Coulibaly, Gideon Emukule, Vieng Khanthamaly, Hassan Zaraket, Imad Cherkaoui, Dinagul Otorbaeva, Kristina Stravidis, Abdulakhad Safarov, Jihene Bettaieb, Ledor S Igboh, Eduardo Azziz-Baumgartner, Artavazd Vanyan, Ani Manukyan, Erida Nelaj, Iria Preza, Alfred Douba, Anderson N'Gattia, Chankham Tengbriacheu, Chansay Pathammavong, Malak Alame, Loubna Alj, Afif Ben Salah, Philipp Lambach, Joseph S Bresee

Background: Although healthcare personnel (HCP) are targeted for influenza vaccination they typically underutilize vaccines especially in low- and middle-income countries. We explored knowledge, attitudes, and practices of HCP about seasonal influenza vaccines (SIV) to identify factors associated with and modifiable barriers to SIV uptake.

Methods: We pooled individual-level data from cross-sectional surveys about SIV conducted among health workers in 12 low- and middle- income countries during 2018-2020 (i.e., Albania, Armenia, Cote d'Ivoire, Kenya, Kyrgyzstan, Lao PDR, Lebanon, Morocco, North Macedonia, Tunisia, Tajikistan, and Uganda). Eleven countries used a standard protocol and questionnaire based on the Health Belief Model to measure perceptions of susceptibility and severity of influenza disease, benefits of, barriers to, and motivators for vaccination. We analyzed attitudes and perceptions among HCP, including acceptance of vaccine for themselves and willingness to recommend vaccines to patients, grouped by the presence/absence of a national influenza vaccination program. Models were adjusted for geographic region.

Results: Our analysis included 10,281 HCP from 12 countries representing four of the six World Health Organization regions: African, Eastern Mediterranean, European, and Western Pacific. The sample was distributed across low income (LIC) (3,183, 31 %), lower-middle (LMIC) (4,744, 46 %), and upper-middle income (UMIC) (2,354, 23 %) countries. Half (50 %) of the countries included in the analysis reported SIV use among HCP in both the year of and the year preceding data collection while the remainder had no influenza vaccination program for HCP. Seventy-four percent (6,341) of HCP reported that they would be willing to be vaccinated if the vaccine was provided free of charge. HCP in LICs were willing to pay prices for SIV representing a higher percentage of their country's annual health expenditure per capita (6.26 % [interquartile range, IQR: 3.13-12.52]) compared to HCP in LMICs and UMICs. HCP in countries with no SIV program were also willing to pay a higher percentage for SIV (5.01 % [IQR: 2.24-8.34]) compared to HCP in countries with SIV programs.. Most (85 %) HCP in our analysis would recommend vaccines to their patients, and those who would accept vaccines for themselves were 3 times more likely to recommend vaccines to their patients (OR 3.1 [95 % CI 1·8, 5·2]).

Conclusion: Increasing uptake of SIV among HCP can amplify positive impacts of vaccination by increasing the likelihood that HCP recommend vaccines to their patients. Successful strategies to achieve increased uptake of vaccines include clear guidance from health authorities, interventions based on behavior change models, and access to vaccine free-of-charge.

背景:尽管医护人员(HCP)是流感疫苗接种的目标人群,但他们对疫苗的利用率通常很低,尤其是在中低收入国家。我们探讨了医护人员对季节性流感疫苗(SIV)的认识、态度和实践,以确定与 SIV 接种相关的因素和可改变的障碍:我们汇集了 2018-2020 年间在 12 个中低收入国家(即阿尔巴尼亚、亚美尼亚、科特迪瓦、肯尼亚、吉尔吉斯斯坦、老挝人民民主共和国、黎巴嫩、摩洛哥、北马其顿、突尼斯、塔吉克斯坦和乌干达)对卫生工作者进行的有关 SIV 的横断面调查的个人层面数据。11 个国家采用了基于健康信念模型的标准方案和调查问卷来衡量对流感疾病易感性和严重程度、接种疫苗的益处、障碍和动机的看法。我们分析了卫生保健人员的态度和看法,包括他们自己对疫苗的接受程度和向病人推荐疫苗的意愿,并按照是否存在国家流感疫苗接种计划进行了分组。根据地理区域对模型进行了调整:我们的分析包括世界卫生组织六个地区中四个地区的 12 个国家的 10,281 名 HCP:我们的分析包括来自 12 个国家的 10,281 名 HCP,分别代表世界卫生组织的六个地区中的四个地区:非洲、东地中海、欧洲和西太平洋。样本分布在低收入 (LIC) 国家(3183 人,占 31%)、中低收入 (LMIC) 国家(4744 人,占 46%)和中高收入 (UMIC) 国家(2354 人,占 23%)。在纳入分析的国家中,有一半(50%)的国家报告说,在数据收集当年和前一年,卫生保健人员中都有使用 SIV 的情况,而其余国家则没有为卫生保健人员制定流感疫苗接种计划。74%(6,341 人)的 HCP 表示,如果免费提供疫苗,他们愿意接种。与低收入和中等收入国家以及超低收入和中等收入国家的初级保健人员相比,低收入和中等收入国家的初级保健人员愿意支付的 SIV 疫苗费用占其国家年度人均医疗支出的比例较高(6.26% [四分位数间距,IQR:3.13-12.52])。与实施 SIV 计划的国家相比,未实施 SIV 计划的国家的保健医生也愿意为 SIV 支付更高的费用(5.01% [IQR: 2.24-8.34])。在我们的分析中,大多数(85%)初级保健医生会向他们的病人推荐疫苗,而那些愿意为自己接种疫苗的人向他们的病人推荐疫苗的可能性要高出三倍(OR 3.1 [95 % CI 1-8, 5-2]):结论:提高 HCP 对 SIV 的接种率可增加 HCP 向其患者推荐疫苗的可能性,从而扩大疫苗接种的积极影响。提高疫苗接种率的成功策略包括卫生当局的明确指导、基于行为改变模式的干预措施以及免费提供疫苗。
{"title":"Healthcare personnel acceptance and recommendations for influenza vaccine in twelve low- and middle-income countries: A pooled analysis from 2018 to 2020.","authors":"Margaret McCarron, Perrine Marcenac, Tat S Yau, Kathryn E Lafond, Malembe S Ebama, Lindsey M Duca, Gayane Sahakyan, Silvia Bino, Daouda Coulibaly, Gideon Emukule, Vieng Khanthamaly, Hassan Zaraket, Imad Cherkaoui, Dinagul Otorbaeva, Kristina Stravidis, Abdulakhad Safarov, Jihene Bettaieb, Ledor S Igboh, Eduardo Azziz-Baumgartner, Artavazd Vanyan, Ani Manukyan, Erida Nelaj, Iria Preza, Alfred Douba, Anderson N'Gattia, Chankham Tengbriacheu, Chansay Pathammavong, Malak Alame, Loubna Alj, Afif Ben Salah, Philipp Lambach, Joseph S Bresee","doi":"10.1016/j.vaccine.2024.01.095","DOIUrl":"https://doi.org/10.1016/j.vaccine.2024.01.095","url":null,"abstract":"<p><strong>Background: </strong>Although healthcare personnel (HCP) are targeted for influenza vaccination they typically underutilize vaccines especially in low- and middle-income countries. We explored knowledge, attitudes, and practices of HCP about seasonal influenza vaccines (SIV) to identify factors associated with and modifiable barriers to SIV uptake.</p><p><strong>Methods: </strong>We pooled individual-level data from cross-sectional surveys about SIV conducted among health workers in 12 low- and middle- income countries during 2018-2020 (i.e., Albania, Armenia, Cote d'Ivoire, Kenya, Kyrgyzstan, Lao PDR, Lebanon, Morocco, North Macedonia, Tunisia, Tajikistan, and Uganda). Eleven countries used a standard protocol and questionnaire based on the Health Belief Model to measure perceptions of susceptibility and severity of influenza disease, benefits of, barriers to, and motivators for vaccination. We analyzed attitudes and perceptions among HCP, including acceptance of vaccine for themselves and willingness to recommend vaccines to patients, grouped by the presence/absence of a national influenza vaccination program. Models were adjusted for geographic region.</p><p><strong>Results: </strong>Our analysis included 10,281 HCP from 12 countries representing four of the six World Health Organization regions: African, Eastern Mediterranean, European, and Western Pacific. The sample was distributed across low income (LIC) (3,183, 31 %), lower-middle (LMIC) (4,744, 46 %), and upper-middle income (UMIC) (2,354, 23 %) countries. Half (50 %) of the countries included in the analysis reported SIV use among HCP in both the year of and the year preceding data collection while the remainder had no influenza vaccination program for HCP. Seventy-four percent (6,341) of HCP reported that they would be willing to be vaccinated if the vaccine was provided free of charge. HCP in LICs were willing to pay prices for SIV representing a higher percentage of their country's annual health expenditure per capita (6.26 % [interquartile range, IQR: 3.13-12.52]) compared to HCP in LMICs and UMICs. HCP in countries with no SIV program were also willing to pay a higher percentage for SIV (5.01 % [IQR: 2.24-8.34]) compared to HCP in countries with SIV programs.. Most (85 %) HCP in our analysis would recommend vaccines to their patients, and those who would accept vaccines for themselves were 3 times more likely to recommend vaccines to their patients (OR 3.1 [95 % CI 1·8, 5·2]).</p><p><strong>Conclusion: </strong>Increasing uptake of SIV among HCP can amplify positive impacts of vaccination by increasing the likelihood that HCP recommend vaccines to their patients. Successful strategies to achieve increased uptake of vaccines include clear guidance from health authorities, interventions based on behavior change models, and access to vaccine free-of-charge.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142094364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A health equity science approach to assessing drivers of COVID-19 vaccination coverage disparities over the course of the COVID-19 pandemic, United States, December 2020-December 2022. 采用健康公平科学方法评估 COVID-19 疫苗接种覆盖率在 COVID-19 大流行期间存在差异的驱动因素,美国,2020 年 12 月至 2022 年 12 月。
Pub Date : 2024-08-01 DOI: 10.1016/j.vaccine.2024.126158
Makhabele Nolana Woolfork, Kambria Haire, Oluyemi Farinu, Jasmine Ruffin, Jennifer M Nelson, Fatima Coronado, Benjamin J Silk, LaTreace Harris, Chastity Walker, Brian J Manns

Introduction: Health equity science examines underlying social determinants, or drivers, of health inequities by building an evidence base to guide action across programs, public health surveillance, policy, and communications efforts. A Social Vulnerability Index (SVI) was utilized during the COVID-19 response to identify areas where inequities exist and support communities with vaccination. We set out to assess COVID-19 vaccination coverage by two SVI themes, Racial and Ethnicity Minority Status and Housing Type and Transportation to examine disparities.

Methods: US county-level COVID-19 vaccine administration data among persons aged 5 years and older reported to the Centers for Disease Control and Prevention from December 14, 2020 to December 14, 2022, were analyzed. Counties were categorized 1) into tertiles (low, moderate, high) according to each SVI theme's level of vulnerability or 2) dichotomized by urban or rural classification. Primary series vaccination coverage per age group were assessed for SVI social factors by SVI theme tertiles or urbanicity.

Results: Older adults aged 65 years and older had the highest vaccination coverage across all vulnerability factors compared with children aged 5-17 years and adults aged 18-64 years. Overall, children and adults had higher vaccination coverage in counties of high vulnerability. Greater vaccination coverage differences were observed by urbanicity as rural counties had some of the lowest vaccination coverage for children and adults.

Conclusion: COVID-19 vaccination efforts narrowed gaps in coverage for adults aged 65 years and older but larger vaccination coverage differences remained among younger populations. Moreover, greater disparities in coverage existed in rural counties. Health equity science approaches to analyses should extend beyond identifying differences by basic demographics such as race and ethnicity and include factors that provide context (housing, transportation, age, and geography) to assist with prioritization of vaccination efforts where true disparities in vaccination coverage exist.

导言:健康公平科学通过建立证据基础来研究造成健康不公平的潜在社会决定因素或驱动因素,从而指导整个计划、公共卫生监测、政策和宣传工作的行动。在 COVID-19 应对行动中,我们使用了社会脆弱性指数 (SVI),以确定存在不公平现象的地区,并为社区提供疫苗接种支持。我们按照 SVI 的两个主题,即种族和族裔少数群体状况以及住房类型和交通状况来评估 COVID-19 疫苗接种覆盖率,以检查差异:分析了 2020 年 12 月 14 日至 2022 年 12 月 14 日期间向美国疾病控制和预防中心报告的美国县级 5 岁及以上人群 COVID-19 疫苗接种数据。1) 根据每个 SVI 主题的易感程度将各县分为三等分(低、中、高),或 2) 按城市或农村分类进行二分。根据 SVI 社会因素,按 SVI 主题三分法或城市化程度对每个年龄组的初级系列疫苗接种覆盖率进行评估:结果:与 5-17 岁的儿童和 18-64 岁的成年人相比,65 岁及以上的老年人在所有脆弱性因素中的疫苗接种覆盖率最高。总体而言,在高脆弱性县,儿童和成人的疫苗接种覆盖率较高。城市地区的疫苗接种率差异更大,因为农村地区的儿童和成人疫苗接种率最低:结论:COVID-19 疫苗接种工作缩小了 65 岁及以上成年人的接种率差距,但年轻人口的接种率差异仍然较大。此外,农村地区的接种率差距更大。健康公平科学的分析方法不应局限于按种族和民族等基本人口统计学特征确定差异,还应包括提供背景情况的因素(住房、交通、年龄和地理位置),以帮助在疫苗接种覆盖率确实存在差异的地方优先开展疫苗接种工作。
{"title":"A health equity science approach to assessing drivers of COVID-19 vaccination coverage disparities over the course of the COVID-19 pandemic, United States, December 2020-December 2022.","authors":"Makhabele Nolana Woolfork, Kambria Haire, Oluyemi Farinu, Jasmine Ruffin, Jennifer M Nelson, Fatima Coronado, Benjamin J Silk, LaTreace Harris, Chastity Walker, Brian J Manns","doi":"10.1016/j.vaccine.2024.126158","DOIUrl":"https://doi.org/10.1016/j.vaccine.2024.126158","url":null,"abstract":"<p><strong>Introduction: </strong>Health equity science examines underlying social determinants, or drivers, of health inequities by building an evidence base to guide action across programs, public health surveillance, policy, and communications efforts. A Social Vulnerability Index (SVI) was utilized during the COVID-19 response to identify areas where inequities exist and support communities with vaccination. We set out to assess COVID-19 vaccination coverage by two SVI themes, Racial and Ethnicity Minority Status and Housing Type and Transportation to examine disparities.</p><p><strong>Methods: </strong>US county-level COVID-19 vaccine administration data among persons aged 5 years and older reported to the Centers for Disease Control and Prevention from December 14, 2020 to December 14, 2022, were analyzed. Counties were categorized 1) into tertiles (low, moderate, high) according to each SVI theme's level of vulnerability or 2) dichotomized by urban or rural classification. Primary series vaccination coverage per age group were assessed for SVI social factors by SVI theme tertiles or urbanicity.</p><p><strong>Results: </strong>Older adults aged 65 years and older had the highest vaccination coverage across all vulnerability factors compared with children aged 5-17 years and adults aged 18-64 years. Overall, children and adults had higher vaccination coverage in counties of high vulnerability. Greater vaccination coverage differences were observed by urbanicity as rural counties had some of the lowest vaccination coverage for children and adults.</p><p><strong>Conclusion: </strong>COVID-19 vaccination efforts narrowed gaps in coverage for adults aged 65 years and older but larger vaccination coverage differences remained among younger populations. Moreover, greater disparities in coverage existed in rural counties. Health equity science approaches to analyses should extend beyond identifying differences by basic demographics such as race and ethnicity and include factors that provide context (housing, transportation, age, and geography) to assist with prioritization of vaccination efforts where true disparities in vaccination coverage exist.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141880000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of community-oriented primary care (COPC) model to generate vaccine demand: The case of a remote fishing community in Cameroon. 利用以社区为导向的初级保健 (COPC) 模式创造疫苗需求:喀麦隆偏远渔业社区的案例。
Pub Date : 2024-07-31 DOI: 10.1016/j.vaccine.2024.126173
Clovis Nchinjoh Sangwe, Michael Ngenge Budzi, Ismael Ngwayi Shifu, Jamin Ghangha Ghangha, Sontsa Nelson Njedock

Background: Cameroon, a country in sub-Saharan Africa, ranks among the top 15 countries worldwide with the highest number of zero-dose (unvaccinated) children. Among other reasons, pockets of hard-to-reach communities that traditionally miss essential healthcare services, including childhood immunization, largely contribute to this sub-optimal vaccination coverage. This is the case of Manoka Health District (MHD), an archipelago district with a zero-dose proportion of 91.7%. High disease burdens such as malaria and water-borne diseases have forced the population to depend on herbalists and roadside drug vendors, eroding trust in the primary healthcare system and worsening vaccine hesitancy. This study, therefore, aims to describe how a project optimized vaccine demand generation in these hard-to-reach settlements using an integrated community health worker service delivery package developed using the Community-oriented primary healthcare (COPC) model.

Methodology: This cross-sectional descriptive study was based on data collected from November 2021 to August 2022 in three project-implementing health areas (Kombo Moukoko, Kooh, and Toube) in the Manoka health district. Data was collected on the integrated health packages offered by Community Health Workers (CHWs). It comprised health education on malaria and water-borne diseases, screening for malaria using Rapid Diagnostic Test (RDT), treatment of under-5 for uncomplicated malaria and diarrhea, conduct of essential Antenatal Care (ANC) services, and vaccination counseling and referral in the three health areas. Microsoft Excel 2013 was used to analyze descriptive data and expressed results as percentages, with tables and column charts used for data visualization. All missing data were considered in the final analysis.

Results: Over 550 under-5 children and 187 pregnant women were identified to be in need of curative and preventive care services during the project period. About 81% of pregnant women received a minimum ANC package by CHWs, and 47% adhered to referrals to health facilities for continuous ANC and delivery. Half of the children under 5 with health issues were diagnosed and managed for uncomplicated malaria. Also, during home visits, 617 under-immunized and zero-dose children less than two years of age were identified, referred, and vaccinated either during an outreach program or at the nearest health post in a neighboring health area, representing about 64% (617/964) of under-2 children identified in these communities. There was a gradual increase from 0% vaccine acceptance post-referral in the first month to 47% after six months and 64% at one year of intervention.

Conclusion: The use of the COPC model to co-develop integrated essential health service packages that meet the needs of communities showed value in building trust and increasing childhood immunization uptake in hard-to-reach communitie

背景:喀麦隆是撒哈拉以南非洲地区的一个国家,是全球零剂量(未接种疫苗)儿童人数最多的 15 个国家之一。除其他原因外,一些传统上难以到达的社区错过了包括儿童免疫接种在内的基本医疗保健服务,这在很大程度上导致了疫苗接种覆盖率不达标。马诺卡卫生区(Manoka Health District,MHD)就是这种情况,该群岛区的零剂量接种率为 91.7%。疟疾和水媒疾病等高发病率迫使人们依赖草药医生和路边药贩,从而削弱了人们对初级医疗保健系统的信任,并加剧了疫苗接种的犹豫不决。因此,本研究旨在描述一个项目如何利用以社区为导向的初级医疗保健(COPC)模式开发的社区卫生工作者综合服务包,在这些难以到达的定居点优化疫苗需求的产生:这项横断面描述性研究基于 2021 年 11 月至 2022 年 8 月期间在马诺卡卫生区的三个项目实施卫生区(Kombo Moukoko、Kooh 和 Toube)收集的数据。收集的数据涉及社区保健员(CHWs)提供的综合保健套餐。其中包括疟疾和水传播疾病的健康教育、使用快速诊断检测(RDT)筛查疟疾、治疗五岁以下儿童的无并发症疟疾和腹泻、提供基本的产前护理(ANC)服务、疫苗接种咨询以及三个卫生区的转诊。分析描述性数据时使用了 Microsoft Excel 2013,结果以百分比表示,数据可视化时使用了表格和柱状图。最终分析考虑了所有缺失数据:结果:在项目实施期间,超过 550 名 5 岁以下儿童和 187 名孕妇被确认需要治疗和预防保健服务。约 81% 的孕妇接受了保健社工提供的最基本的产前保健服务,47% 的孕妇坚持转诊到医疗机构接受持续的产前保健和分娩服务。半数有健康问题的 5 岁以下儿童得到了无并发症疟疾的诊断和治疗。此外,在家访过程中,还发现了 617 名免疫接种不足和零剂量接种的两岁以下儿童,他们在外联计划期间或在邻近卫生区最近的卫生站进行了转诊和疫苗接种,约占这些社区发现的两岁以下儿童的 64%(617/964)。转介后第一个月的疫苗接受率为 0%,六个月后逐渐上升到 47%,干预一年后上升到 64%:结论:利用 COPC 模式共同开发满足社区需求的综合基本医疗服务包,对于在难以到达的社区建立信任和提高儿童免疫接种率具有重要价值。
{"title":"The use of community-oriented primary care (COPC) model to generate vaccine demand: The case of a remote fishing community in Cameroon.","authors":"Clovis Nchinjoh Sangwe, Michael Ngenge Budzi, Ismael Ngwayi Shifu, Jamin Ghangha Ghangha, Sontsa Nelson Njedock","doi":"10.1016/j.vaccine.2024.126173","DOIUrl":"https://doi.org/10.1016/j.vaccine.2024.126173","url":null,"abstract":"<p><strong>Background: </strong>Cameroon, a country in sub-Saharan Africa, ranks among the top 15 countries worldwide with the highest number of zero-dose (unvaccinated) children. Among other reasons, pockets of hard-to-reach communities that traditionally miss essential healthcare services, including childhood immunization, largely contribute to this sub-optimal vaccination coverage. This is the case of Manoka Health District (MHD), an archipelago district with a zero-dose proportion of 91.7%. High disease burdens such as malaria and water-borne diseases have forced the population to depend on herbalists and roadside drug vendors, eroding trust in the primary healthcare system and worsening vaccine hesitancy. This study, therefore, aims to describe how a project optimized vaccine demand generation in these hard-to-reach settlements using an integrated community health worker service delivery package developed using the Community-oriented primary healthcare (COPC) model.</p><p><strong>Methodology: </strong>This cross-sectional descriptive study was based on data collected from November 2021 to August 2022 in three project-implementing health areas (Kombo Moukoko, Kooh, and Toube) in the Manoka health district. Data was collected on the integrated health packages offered by Community Health Workers (CHWs). It comprised health education on malaria and water-borne diseases, screening for malaria using Rapid Diagnostic Test (RDT), treatment of under-5 for uncomplicated malaria and diarrhea, conduct of essential Antenatal Care (ANC) services, and vaccination counseling and referral in the three health areas. Microsoft Excel 2013 was used to analyze descriptive data and expressed results as percentages, with tables and column charts used for data visualization. All missing data were considered in the final analysis.</p><p><strong>Results: </strong>Over 550 under-5 children and 187 pregnant women were identified to be in need of curative and preventive care services during the project period. About 81% of pregnant women received a minimum ANC package by CHWs, and 47% adhered to referrals to health facilities for continuous ANC and delivery. Half of the children under 5 with health issues were diagnosed and managed for uncomplicated malaria. Also, during home visits, 617 under-immunized and zero-dose children less than two years of age were identified, referred, and vaccinated either during an outreach program or at the nearest health post in a neighboring health area, representing about 64% (617/964) of under-2 children identified in these communities. There was a gradual increase from 0% vaccine acceptance post-referral in the first month to 47% after six months and 64% at one year of intervention.</p><p><strong>Conclusion: </strong>The use of the COPC model to co-develop integrated essential health service packages that meet the needs of communities showed value in building trust and increasing childhood immunization uptake in hard-to-reach communitie","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141877134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010. 日本的小儿中耳炎:对 2001 年和 2010 年出生的肺炎球菌结合疫苗接种前后两个时期的全国性纵向研究。
Pub Date : 2024-07-25 Epub Date: 2024-05-17 DOI: 10.1016/j.vaccine.2024.05.020
Kensuke Uraguchi, Naomi Matsumoto, Toshiharu Mitsuhashi, Soshi Takao, Seiichiro Makihara, Mizuo Ando, Takashi Yorifuji

Background: Otitis media (OM) is a prevalent respiratory disease in children and poses significant public health challenges due to its impact on child health and economic burdens. However, there have no nationwide epidemiological studies conducted in Japan. This study investigates the epidemiological trends of OM in Japan, taking into account the impact of the 7-valent pneumococcal conjugate vaccine (PCV7) introduction.

Method: This study was retrospective cohort study using secondary data on the nationwide longitudinal birth cohort. This survey followed two cohorts born in 2001 (pre-PCV era) and 2010 (post-PCV era) until the age of 9. Every year, parents were surveyed about their children's health status, including occurrences of OM. The annual period prevalence and cumulative incidence of OM were assessed in this study, and the two cohorts were compared using a modified Poisson regression model adjusted environmental factors with the 2001 cohort as reference.

Result: The study included 47,015 children from the 2001 cohort and 38,554 from the 2010 cohort. Peak annual period prevalence of OM varied by era. Cumulative incidence was 13.8 % for the 2001 cohort and 18.5 % for the 2010 cohort by 1.5 years of age and 28.9 % and 33.3 %, respectively, by 3.5 years of age. In particular, from the fourth survey onward, covering ages 2.5-3.5 years, a shift was observed from an increased risk to a decreased risk of OM.

Conclusion: This nationwide longitudinal study emphasizes variations in OM epidemiology across Japan over time, with changes potentially influenced by the introduction of PCV7. In this study, due to the absence of individual PCV7 vaccination data, the effect of PCV7 was estimated based on the vaccination rate at the population level. The results suggest a notable decrease in the incidence of OM in later years, aligning with the increased uptake of PCV7.

背景:中耳炎(OM)是儿童常见的呼吸道疾病,由于其对儿童健康和经济负担的影响,给公共卫生带来了巨大挑战。然而,日本尚未开展全国性的流行病学研究。本研究考虑到 7 价肺炎球菌结合疫苗(PCV7)引入的影响,对日本 OM 的流行趋势进行了调查:本研究是一项回顾性队列研究,使用的是全国纵向出生队列的二手数据。这项调查分别对 2001 年(接种 PCV 前)和 2010 年(接种 PCV 后)出生的两批儿童进行了跟踪调查,直至他们 9 岁。本研究评估了 OM 的年度流行率和累积发病率,并以 2001 年的队列为参照,使用调整了环境因素的改良泊松回归模型对两个队列进行了比较:研究包括 2001 年队列中的 47 015 名儿童和 2010 年队列中的 38 554 名儿童。OM的年高峰期发病率因年代而异。1.5 岁时,2001 年组群的累计发病率为 13.8%,2010 年组群为 18.5%,3.5 岁时分别为 28.9% 和 33.3%。特别是在 2.5-3.5 岁的第四次调查中,观察到 OM 风险从增加转为降低:这项全国范围的纵向研究强调了随着时间的推移,日本各地 OM 流行病学的变化,其中的变化可能受到 PCV7 引入的影响。在本研究中,由于缺乏个人 PCV7 疫苗接种数据,PCV7 的影响是根据人群接种率估算的。结果表明,随着 PCV7 接种率的提高,OM 的发病率在后来几年明显下降。
{"title":"Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010.","authors":"Kensuke Uraguchi, Naomi Matsumoto, Toshiharu Mitsuhashi, Soshi Takao, Seiichiro Makihara, Mizuo Ando, Takashi Yorifuji","doi":"10.1016/j.vaccine.2024.05.020","DOIUrl":"10.1016/j.vaccine.2024.05.020","url":null,"abstract":"<p><strong>Background: </strong>Otitis media (OM) is a prevalent respiratory disease in children and poses significant public health challenges due to its impact on child health and economic burdens. However, there have no nationwide epidemiological studies conducted in Japan. This study investigates the epidemiological trends of OM in Japan, taking into account the impact of the 7-valent pneumococcal conjugate vaccine (PCV7) introduction.</p><p><strong>Method: </strong>This study was retrospective cohort study using secondary data on the nationwide longitudinal birth cohort. This survey followed two cohorts born in 2001 (pre-PCV era) and 2010 (post-PCV era) until the age of 9. Every year, parents were surveyed about their children's health status, including occurrences of OM. The annual period prevalence and cumulative incidence of OM were assessed in this study, and the two cohorts were compared using a modified Poisson regression model adjusted environmental factors with the 2001 cohort as reference.</p><p><strong>Result: </strong>The study included 47,015 children from the 2001 cohort and 38,554 from the 2010 cohort. Peak annual period prevalence of OM varied by era. Cumulative incidence was 13.8 % for the 2001 cohort and 18.5 % for the 2010 cohort by 1.5 years of age and 28.9 % and 33.3 %, respectively, by 3.5 years of age. In particular, from the fourth survey onward, covering ages 2.5-3.5 years, a shift was observed from an increased risk to a decreased risk of OM.</p><p><strong>Conclusion: </strong>This nationwide longitudinal study emphasizes variations in OM epidemiology across Japan over time, with changes potentially influenced by the introduction of PCV7. In this study, due to the absence of individual PCV7 vaccination data, the effect of PCV7 was estimated based on the vaccination rate at the population level. The results suggest a notable decrease in the incidence of OM in later years, aligning with the increased uptake of PCV7.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Countering vaccine misinformation: Designing a learning resource for healthcare workers in eight countries. 消除疫苗误导:为八个国家的医护人员设计学习资源。
Pub Date : 2024-07-11 DOI: 10.1016/j.vaccine.2024.06.058
Emily Miller, Alex Michel, Prachi Singh, Rupali Limaye

In response to the pervasive challenges posed by online health misinformation, our objective was to develop a training program aimed at enhancing the skills and confidence of healthcare workers in recognizing and effectively responding to misinformation, with a particular focus on vaccinations. This article discusses the design of a training program aimed at equipping healthcare workers with the skills to combat health misinformation, offering theoretical foundations for integrating evidence-based strategies into problem-based learning to help learners retain and apply information, and also shares examples and insights gained from its application across diverse learner groups. The training curriculum integrates evidence-based misinformation intervention strategies, learner engagement strategies and draws from authentic scenarios across diverse cultural contexts. The trainings were administered from January through July 2023 to 287 participants across eight countries (Cameroon, Guyana, India, Kenya, Mozambique, Nigeria, Philippines, and the United States) in English, French, Spanish, and Portuguese. Throughout the implementation of the training, a key emphasis was placed on a learner-driven approach that fostered real-world application. Participants engaged in role-playing exercises and problem-solving sessions, enabling them to practice their newfound skills in a controlled setting. Our findings contribute to the literature of participatory, problem-based learning for healthcare professionals and vaccine communication and misinformation response, and can serve as a resource for practitioners implementing similar trainings.

为了应对网络健康误导信息所带来的普遍挑战,我们的目标是开发一个培训项目,旨在提高医疗工作者识别和有效应对误导信息的技能和信心,尤其侧重于疫苗接种。本文讨论了旨在使医护人员掌握应对健康误导信息技能的培训项目的设计,为将循证策略融入基于问题的学习提供了理论基础,以帮助学习者保留和应用信息,同时还分享了在不同学习者群体中应用该培训项目的实例和心得。培训课程整合了基于证据的错误信息干预策略、学习者参与策略,并借鉴了不同文化背景下的真实情景。从 2023 年 1 月到 7 月,在八个国家(喀麦隆、圭亚那、印度、肯尼亚、莫桑比克、尼日利亚、菲律宾和美国)以英语、法语、西班牙语和葡萄牙语对 287 名参与者进行了培训。在整个培训实施过程中,重点强调以学员为主导的方法,促进实际应用。学员们参与了角色扮演练习和问题解决课程,使他们能够在可控环境中练习新学到的技能。我们的研究结果为医疗保健专业人员参与式、基于问题的学习以及疫苗沟通和错误信息应对方面的文献做出了贡献,并可作为实施类似培训的从业人员的资源。
{"title":"Countering vaccine misinformation: Designing a learning resource for healthcare workers in eight countries.","authors":"Emily Miller, Alex Michel, Prachi Singh, Rupali Limaye","doi":"10.1016/j.vaccine.2024.06.058","DOIUrl":"https://doi.org/10.1016/j.vaccine.2024.06.058","url":null,"abstract":"<p><p>In response to the pervasive challenges posed by online health misinformation, our objective was to develop a training program aimed at enhancing the skills and confidence of healthcare workers in recognizing and effectively responding to misinformation, with a particular focus on vaccinations. This article discusses the design of a training program aimed at equipping healthcare workers with the skills to combat health misinformation, offering theoretical foundations for integrating evidence-based strategies into problem-based learning to help learners retain and apply information, and also shares examples and insights gained from its application across diverse learner groups. The training curriculum integrates evidence-based misinformation intervention strategies, learner engagement strategies and draws from authentic scenarios across diverse cultural contexts. The trainings were administered from January through July 2023 to 287 participants across eight countries (Cameroon, Guyana, India, Kenya, Mozambique, Nigeria, Philippines, and the United States) in English, French, Spanish, and Portuguese. Throughout the implementation of the training, a key emphasis was placed on a learner-driven approach that fostered real-world application. Participants engaged in role-playing exercises and problem-solving sessions, enabling them to practice their newfound skills in a controlled setting. Our findings contribute to the literature of participatory, problem-based learning for healthcare professionals and vaccine communication and misinformation response, and can serve as a resource for practitioners implementing similar trainings.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141602410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccine value profile for schistosomiasis 血吸虫病疫苗价值概况
Pub Date : 2024-07-01 DOI: 10.1016/j.vaccine.2024.05.068
Gavin Yamey, Kaci Kennedy McDade, Roy M. Anderson, S. Bartsch, M. Bottazzi, D. Diemert, P. Hotez, Bruce Y. Lee, Donald McManus, Adebayo J. Molehin, M. Roestenberg, David Rollinson, Afzal A. Siddiqui, Miriam Tendler, Joanne P. Webster, Hong You, Raphaël M. Zellweger, Caroline Marshall
{"title":"Vaccine value profile for schistosomiasis","authors":"Gavin Yamey, Kaci Kennedy McDade, Roy M. Anderson, S. Bartsch, M. Bottazzi, D. Diemert, P. Hotez, Bruce Y. Lee, Donald McManus, Adebayo J. Molehin, M. Roestenberg, David Rollinson, Afzal A. Siddiqui, Miriam Tendler, Joanne P. Webster, Hong You, Raphaël M. Zellweger, Caroline Marshall","doi":"10.1016/j.vaccine.2024.05.068","DOIUrl":"https://doi.org/10.1016/j.vaccine.2024.05.068","url":null,"abstract":"","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141845885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vaccine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1